Clinical Trial Update: Phase IV Study in Asthma Subjects for Dry Powder Inhaler (DPI) Versus (vs) Metered Dose Inhaler (MDI) Correct Use [Phase 4]

View source ↗

Summary

A Phase IV trial comparing dry powder inhaler versus metered-dose inhaler for correct use in asthma patients; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• DPI (dry powder inhaler) vs MDI (metered-dose inhaler)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2018-03-16